Ivana Campia
Ispra, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Corrigendum to 'A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells' [Journal of Controlled Release 149(2) (2011) 196-205].
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 10, 2026
OECD harmonised template 201: Structuring and reporting mechanistic information to foster the integration of new approach methodologies for hazard and risk assessment of chemicals.
Journal: Regulatory toxicology and pharmacology : RTP
Published: December 23, 2022
Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer's disease, breast cancer and prostate cancer.
Journal: Health research policy and systems
Published: October 03, 2022
Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
Journal: Computational toxicology (Amsterdam, Netherlands)
Published: August 25, 2021
Towards a qAOP framework for predictive toxicology - Linking data to decisions.
Journal: Computational toxicology (Amsterdam, Netherlands)
Published: April 27, 2021
Alzheimer's Disease, and Breast and Prostate Cancer Research: Translational Failures and the Importance to Monitor Outputs and Impact of Funded Research.
Journal: Animals : an open access journal from MDPI
Published: May 26, 2020
Creating a Structured AOP Knowledgebase via Ontology-Based Annotations.
Journal: Applied in vitro toxicology
Published: July 31, 2018
Chemical alternatives assessment of different flame retardants - A case study including multi-walled carbon nanotubes as synergist.
Journal: Environment international
Published: October 28, 2016
Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells.
Journal: Oncotarget
Published: September 09, 2014
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.
Journal: Oncotarget
Published: August 28, 2014
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma.
Journal: Oncotarget
Published: August 28, 2014
Last Updated: 09/26/2026